Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
Where this comes from
- Record sourced from PubMed, PMID 29715294.
- Also identified by DOI 10.1371/journal.pone.0196885 and PMC identifier 5929502.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0181757.].